Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice
about
HMGB1 cytoplasmic translocation in patients with acute liver failure.Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.The effect of erythropoietin on normal and neoplastic cells.Multiple doses of erythropoietin impair liver regeneration by increasing TNF-alpha, the Bax to Bcl-xL ratio and apoptotic cell deathLimited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use.Darbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-β.Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.Darbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice.Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia.Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.Erythropoietin-induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneous tissue from ischemic damage.Liver-specific Fas silencing prevents galactosamine/lipopolysaccharide-induced liver injury.
P2860
Q33846620-DD38D520-919A-4D5D-8BAF-131F0A6A4674Q34219629-FD685F6F-792A-4400-97B8-509A16C77613Q34291437-4A23E4EA-98B8-40E9-BA42-779B2D42D918Q36993016-FC95FD84-F6C8-4750-9847-A779D2116A96Q37137985-FAE7007A-1E22-4B9C-880E-1BF1E774928CQ37247753-061D9AE8-2142-42E7-9E62-BF45C5903299Q37995093-EFD75F34-FF7C-4B03-9CCB-248B21808FE2Q39121853-EA01300F-683D-4D0F-98DE-2787CA2309DBQ39937560-5D87AEF3-2373-46E8-87E5-D88422766E15Q42393136-80C9C2F1-CF02-442C-9E1F-B2E4AF718DFDQ43010284-317B50BF-591A-472F-869E-8D2BFE25A115Q44134497-6DF52CDD-C4CE-4FCD-884E-9B69BF776F51Q44902660-8F3826F5-5AFE-43A8-B4CC-E83A3199C9DDQ53360970-FE393ACA-A3D7-4401-965D-293A5D353EF0Q53640671-548B772F-6718-4F2B-9362-A6FA6330FC42
P2860
Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Attenuation of inflammation an ...... in acute liver failure of mice
@ast
Attenuation of inflammation an ...... in acute liver failure of mice
@en
type
label
Attenuation of inflammation an ...... in acute liver failure of mice
@ast
Attenuation of inflammation an ...... in acute liver failure of mice
@en
prefLabel
Attenuation of inflammation an ...... in acute liver failure of mice
@ast
Attenuation of inflammation an ...... in acute liver failure of mice
@en
P2093
P2860
P1476
Attenuation of inflammation an ...... in acute liver failure of mice
@en
P2093
Brigitte Vollmar
Christian Eipel
Katja Klemm
Kerstin Abshagen
Khoi Le Minh
Michael D Menger
P2860
P304
P356
10.2353/AJPATH.2007.061056
P407
P577
2007-06-01T00:00:00Z